94P Patient-reported outcomes (PROs) following sintilimab (sint) plus pemetrexed (pem) and platinum (plt) based chemotherapy as first-line therapy for locally advanced or metastatic nonsquamous NSCLC: A randomized, double-blind, phase III study (Orient-11)

Subjects

Subjects :

*PEMETREXED
*PLATINUM
*NON-small-cell lung carcinoma
*CANCER chemotherapy
*METASTASIS

Details

Language :

English

ISSN :

09237534

Volume :

32

Database :

Academic Search Index

Journal :

Annals of Oncology

Publication Type :

Academic Journal

Accession number :

153829397

Full Text :

https://doi.org/10.1016/j.annonc.2021.10.112